| Literature DB >> 30948761 |
Pei Shen1, Qianyang Xie1, Zhigui Ma1, Ahmed Abdelrehem2, Shanyong Zhang3, Chi Yang4.
Abstract
This study aims to establish a new staging system of temporomandibular joint (TMJ) anterior disc displacement (ADD) and evaluate its role in guiding the treatment plan. A consecutive sample of 522 juvenile patients (780 joints) diagnosed as ADD based on magnetic resonance imaging (MRI) was included and analyzed. 674 joints received TMJ treatments according to our staging system, while 106 joints rejected any treatment; only for follow-up. The outcomes were judged according to our success criteria. The prognosis of our staging system was also evaluated in comparison to Wilkes classification. Kaplan-Meier survival analysis showed that significant stratifications of the ameliorative rate were found at all subgroups within any two stages in our staging system, except for subgroups between stages 0 and 1, stages 2 and 3, and stages 3 and 4. After analyzing the interactions between different candidate prognostic factors in a Cox model, the relative risks of deterioration of ADD included treatment methods (HR = 42.94, P < 0.0001), disease course (HR = 0.98, P = 0.0019), stages of ADD (HR = 3.81, 9.62, 12.14, P = 0.016, 0.000,0.000 respectively for stage 2, stage 3 and stage 4) and the interaction between ADD stages and treatment methods. The C index of this model was 0.87. The new staging system of TMJ ADD appears reliable, and benefits to making treatment planning and predicting the prognosis.Entities:
Mesh:
Year: 2019 PMID: 30948761 PMCID: PMC6449509 DOI: 10.1038/s41598-019-42081-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Descriptive Statistics of the Patients.
| Variable | Value | Percentage |
|---|---|---|
| Age | 15.8 ± 3.6 | |
| Gender | ||
| Male | 126 | |
| Female | 396 | |
| joints | 780 | |
| Disease course(Mo) | 25.6 ± 15.5 | |
| Our staging | ||
| 0 | 253 | 32.44% |
| 1 | 223 | 28.59% |
| 2 | 111 | 14.23% |
| 3A | 120 | 15.38% |
| 3B | 25 | 3.21% |
| 4A | 28 | 3.59% |
| 4B | 20 | 2.56% |
| Wilkes staging | ||
| 1 | 27 | 3.46% |
| 2 | 108 | 13.85% |
| 3 | 303 | 38.85% |
| 4 | 249 | 31.92% |
| 5 | 93 | 11.92% |
| Treatment method | ||
| Yes | 674 | 86.41% |
| No | 106 | 13.59% |
| Follow-up time | 20.0 ± 16.8 | |
Figure 1Kaplan–Meier survival curves by patient subtype with different staging systems. Overall ameliorative curves of subgroups of patients with both staging systems (X: Ameliorative rate (%); Y: Follow time in month). (A) The ameliorative curves of subgroups of patients with Wilkes staging. (B) The ameliorative curves of subgroups of patients with our staging system.
Univariate and Multivariate Analyses for Deterioration of ADD Patients.
| variables | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| Hazard ratio (95%CI) | P | Hazard ratio (95%CI) | P | |
| gender - M vs F | 0.66 (0.41–1.05) | 0.0809 | ||
| Age | 1.22 (1.11–1.34) | <0.0001 | ||
| Disease course | 1.02 (0.75–1.37) | 0.9226 | 0.98 (0.97–0.99) | 0.0019 |
| Wilkes staging | ||||
| 1 vs 3 | 3.44 (1.61–7.34) | 0.0703 | ||
| 2 vs 3 | 1.59 (0.83–3.04) | 0.0014 | ||
| 4 vs 3 | 2.56 (1.61–4.07) | 0.4139 | ||
| 5 vs 3 | 4.11 (2.44–6.94) | 0.6359 | ||
| Our staging | ||||
| 1 vs 0 | 1.22 (0.67–2.25) | 0.5121 | 1.65 (0.54–5.05) | 0.3791 |
| 2 vs 0 | 2.39 (1.32–4.33) | 0.0042 | 3.81 (1.32–4.33) | 0.0167 |
| 3 vs 0 | 3.97 (2.34–6.73) | <0.0001 | 9.62 (3.69–25.08) | <0.0001 |
| 4 vs 0 | 5.55 (3.11–9.92) | <0.0001 | 12.14 (4.09–36.01) | <0.0001 |
| Treatment | ||||
| (no vs yes) | 13.25 (9.39–18.70) | <0.0001 | 42.94 (15.38–119.92) | <0.0001 |
| Our stage 1 * treatment(yes) | 0.86(0.23–3.30) | 0.83 | ||
| Our stage 2 * treatment(yes) | 0.3(0.08–1.11) | 0.0713 | ||
| Our stage 3 * treatment(yes) | 0.19(0.06–0.61) | 0.0053 | ||
| Our stage 4 * treatment(yes) | 0.14(0.04–0.49) | 0.0024 | ||
Figure 2Nomogram (Cox model) Predicted 60 months deteriorative probability. Bootstrap estimate of calibration accuracy for five-year(60 months) estimates from the final Cox model. Dots correspond to apparent predictive accuracy. X marks the bootstrap-corrected estimates.
Stage for Juvenile TMJ Disc Displacement Based on MRI.
| stage | Disc | Condyle | Marrow |
|---|---|---|---|
| Stage 0 | Basic shape | Normal condylar shape and height | Normal volume and quality |
| Stage 1 | Basic shape | Mild and local condylar resorption, but normal condylar height | Partially reduced on the top |
| Stage 2 | Basic shape | Moderate condylar resorption, reduced condylar height. | Mildly reduced |
| Stage 3 | Basic shape or distorted | Severe condylar resorption | Moderately reduced |
| 3A | Basic shape remains, or mildly distorted and shortened | Small, but basic shape is present | Moderately reduced |
| 3B | Severely distorted and shortened | Small, but basic shape is present | Moderately reduced |
| Stage 4 | Basic shape or distorted | Severe condylar resorption | Moderately reduced with inflammatory changes, or severe reduced, or absent |
| 4A | Basic shape remains or distorted. Perforation is common | Severe resorption, loss of integrity of cortical bone. | Moderately reduced with severe inflammatory changes |
| 4B | Basic shape remains or distorted. Perforation is common | Severe resorption, or complete resorption | Severe reduced, or absent |
Figure 3Juvenile TMJ anterior disc displacement staging system.